Clearside Biomedical, Inc. Announces Pricing of Initial Public Offering
01 juin 2016 23h15 HE
|
Clearside Biomedical, Inc.
ALPHARETTA, Ga., June 01, 2016 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a late-stage clinical biopharmaceutical company developing first-in-class drug therapies to treat...